| Literature DB >> 36093393 |
Abstract
Although collaborative care is increasingly being implemented in the treatment of various diseases, there are currently no related studies on its effects in endometrial cancer patients after laparoscopic treatment. Thus, this study is aimed at investigating the significance of an integrated medical and nursing care model for women with gynecologic malignant tumors who underwent laparoscopic treatment. The patients were randomly divided into a medical-nursing integrated nursing group (study group) and a general nursing group (control group). Their serum carbohydrate antigen 19-9 (CA19-9), human epididymal protein 4 (HE4), CA15-3, and CA125 levels were measured at admission, 7 and 15 days after admission, and 30 days after discharge. Their first postoperative flatulence time, eating time, and hospitalization duration were recorded, and the self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were used to evaluate the psychological state of the patients. A questionnaire survey was also used to evaluate their satisfaction with nursing. Adverse events within 2 years of follow-up were recorded. The results showed that the clinical performance of the study group was significantly better than that of the control group. Further, the study group demonstrated significantly lower serum tumor marker levels, SAS score, SDS score, and incidence of adverse events at 7 and 15 days after admission and 30 days after discharge and higher nursing satisfaction than the control group. Thus, the collaborative nursing mode might be more conducive to the recovery of women who have underwent laparoscopic treatment for gynecologic malignant tumors than normal routine nursing.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36093393 PMCID: PMC9462985 DOI: 10.1155/2022/9910841
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Basic characteristics of patients from the study and control groups.
| Characteristics | Study group ( | Control group ( |
|
|
|---|---|---|---|---|
| Age (years) | 61.00 ± 9.54 | 61.69 ± 6.86 | 1.402 | 0.161 |
| Height (cm) | 158.64 ± 5.82 | 158.47 ± 5.70 | 0.488 | 0.626 |
| Weight (kg) | 61.66 ± 7.18 | 62.27 ± 5.80 | 1.581 | 0.114 |
| Education background, | 2.172 | 0.338 | ||
| Elementary school | 384 (67.1) | 407 (71.2) | ||
| Senior high school | 127 (22.2) | 112 (19.6) | ||
| College and above | 61 (10.7) | 53 (9.4) | ||
| Age of onset (years) | 55.51 ± 9.54 | 55.21 ± 7.09 | 1.393 | 0.164 |
| Tumor staging, | 2.219 | 0.528 | ||
| Stage 1 | 295 (51.6) | 288 (50.4) | ||
| Stage 2 | 96 (16.8) | 95 (16.6) | ||
| Stage 3 | 116 (20.2) | 134 (23.4) | ||
| Stage 4 | 65 (11.4) | 55 (9.6) | ||
| Histological classification, | 1.850 | 0.174 | ||
| Endometrioid adenocarcinoma | 524 (91.6) | 536 (93.7) | ||
| Other types of cancer | 48 (8.4) | 36 (6.3) | ||
| Past medical history, | 2.386 | 0.122 | ||
| Related cases | 480 (83.9) | 460 (80.4) | ||
| Unrelated cases | 92 (16.1) | 112 (19.6) | ||
| Complications, | 2.092 | 0.554 | ||
| Hemorrhage | 340 (59.4) | 329 (57.5) | ||
| Infection | 168 (29.4) | 179 (31.3) | ||
| Intestinal problems | 31 (5.4) | 24 (4.2) | ||
| Other | 33 (5.8) | 40 (7.0) |
∗ P value vs. control group.
Figure 1Comparison of serum tumor marker level and psychological scores between the collaborative and routine care groups. (a) Serum level of CA19-9, HE4, CA153, and CA125 of the two groups at different admission periods. (b) Comparison of SAS and SDS scores of the two groups at different admission periods. ∗P < 0.05 and ∗∗P < 0.01 vs. routine care group.
Comparison of relevant clinical indicators during hospitalization between the two groups.
| Variables | Study group (days) | Control group (days) |
|
|
|---|---|---|---|---|
| Time to first postoperative exhaust time | 4.52 ± 1.10 | 7.88 ± 1.96 | 35.713 | <0.001 |
| Time to first postoperative food-taking | 5.46 ± 1.70 | 6.44 ± 1.10 | 11.544 | <0.001 |
| Hospital stay | 24.85 ± 4.42 | 29.18 ± 2.60 | 20.163 | <0.001 |
∗ P value vs. control group.
Comparison of patients' satisfaction between the two groups.
| Variables | Very satisfied, | Satisfied, | Dissatisfied, | Degree of satisfaction |
|---|---|---|---|---|
| Study group | 347 (60.7) | 206 (36.0) | 19 (3.3) | 96.67% |
| Control group | 233 (40.7) | 240 (42.0) | 99 (17.3) | 82.69% |
|
| 60.475 | |||
|
| <0.001∗ |
Note: a satisfaction score of 80 or above is considered very satisfied, a score of 60 to 79 (including 60 and 79) is considered satisfied, and a score of less than 60 (exclusive) is considered unsatisfied. ∗P value vs. control group.
Comparison of the incidence rate of adverse events and complications after 2-year follow-up between the two groups.
| Variables | Study group, | Control group, |
|
|
|---|---|---|---|---|
| Fever | 26 | 85 | 34.730 | <0.001 |
| Lymphocele | 21 | 61 | 21.019 | <0.001 |
| Intestinal obstruction | 19 | 75 | 36.348 | <0.001 |
| Poor healing of vaginal stump | 1 | 11 | 8.422 | 0.004 |
| Poor healing of abdominal incisions | 2 | 16 | 11.063 | 0.001 |
| Urinary retention | 0 | 13 | 13.149 | <0.001 |
| Abdominal bleeding | 2 | 25 | 20.066 | <0.001 |
| Vesicovaginal fistula | 3 | 26 | 18.716 | <0.001 |
| Lung infection | 2 | 34 | 29.369 | <0.001 |
| Brain obstruction | 1 | 15 | 12.242 | <0.001 |
| Pulmonary embolism | 0 | 13 | 13.149 | <0.001 |
| Ureteral fistula | 0 | 11 | 11.107 | <0.001 |
∗ P value vs. control group.